1-11 of 11
Yumeng Zhang
Close
Sort by
Journal Articles

A Retrospective Study of Extracorporeal Photopheresis (ECP) in Treatment of Cutaneous T-Cell Lymphoma (CTCL) Evaluating Global, Skin and Blood Responses

Ning Dong, Shubham Jaiswal, Sushmita Khadka, Cathelencia Francisque, Yumeng Zhang, Lewis Glass, Kaaron Benson, Hien Liu, Lubomir Sokol
Journal: Blood
Blood (2023) 142 (Supplement 1): 3078.
https://doi.org/10.1182/blood-2023-191313
Published: 2023
Journal Articles

Mogamulizumab-Associated Rash (MAR) Correlates with Longer Progression Free Survival in Cutaneous T Cell Lymphoma (CTCL)

Bei Hu, Shebli Atrash, Leah Cohen, Stefan K. Barta, Yumeng Zhang, Lubomir Sokol, Amy Ayers, Luis E Malpica Castillo, Steven R Hwang, N. Nora Bennani, David Wada, Aung M Tun, Tamara K. Moyo, Nilanjan Ghosh, Michi M Shinohara
Journal: Blood
Blood (2022) 140 (Supplement 1): 1488–1490.
https://doi.org/10.1182/blood-2022-166887
Published: 2022
Journal Articles

Autologous Hematopoietic Cell Transplant Consolidation for First Response Is Associated with Longer Survival in Patients with Nodal Peripheral T-Cell Lymphoma

Yumeng Zhang, Ashley Rose, Jennifer Eatrides, Hayder Saeed, Bijal D. Shah, Aleksandr Lazaryan, Farhad Khimani, Javier Pinilla Ibarz, Hien D. Liu, Frederick L. Locke, Michael D. Jain, Mohamed A. Kharfan-Dabaja, Jongphil Kim, Ling Zhang, Ernesto Ayala, Taiga Nishihori, Lubomir Sokol
Journal: Blood
Blood (2022) 140 (Supplement 1): 6569–6570.
https://doi.org/10.1182/blood-2022-168347
Published: 2022
Journal Articles

Comparing Survival Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Nodal Peripheral T-Cell Lymphoma

Yumeng Zhang, Jennifer Eatrides, Ashley Rose, Ling Zhang, Farhad Khimani, Aleksandr Lazaryan, Bijal D. Shah, Hayder Saeed, Michael D. Jain, Hien D. Liu, Frederick L. Locke, Javier Pinilla Ibarz, Jongphil Kim, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Lubomir Sokol, Taiga Nishihori
Journal: Blood
Blood (2022) 140 (Supplement 1): 10634–10636.
https://doi.org/10.1182/blood-2022-169200
Published: 2022
Journal Articles

Molecular Profiles and Clinical Features of Myeloproliferative Neoplasms Unclassifiable (MPN-U) with and without JAK2 / CALR / MPL Mutations

Curtis Gravenmier, Yumeng Zhang, Nagehan Pakasticali, Lynn C. Moscinski, Jinming Song, Ling Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12248–12249.
https://doi.org/10.1182/blood-2022-170665
Published: 2022
Journal Articles

Clinical Features and Treatment Outcomes of Large Granular Lymphocytic Leukemia Coexisting with Autoimmune Diseases

Ning Dong, Franco Castillo Tokumori, Leidy Isenalumhe, Yumeng Zhang, Ankita Tandon, Todd C. Knepper, Haipeng Shao, Ling Zhang, Lubomir Sokol
Journal: Blood
Blood (2021) 138 (Supplement 1): 1391.
https://doi.org/10.1182/blood-2021-151477
Published: 2021
Journal Articles

Upfront Targeted Tyrosine Kinase Inhibitor Therapy Improves Outcome in Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia

Yumeng Zhang, Chuanyi M. Lu, Endi Wang, Lynh Nguyen, Marietya Lauw, Somedeb Ball, Ning C. Dong, Lynn C. Moscinski, Onyee Chan, Seongseok Yun, Lubomir Sokol, Bijal D. Shah, Jeffrey E. Lancet, Andrew T. Kuykendall, Eric Padron, Ling Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3658.
https://doi.org/10.1182/blood-2021-151654
Published: 2021
Journal Articles

Outcome with Hypomethylating Agent and Venetoclax Combination in Patients with Chronic Myelomonocytic Leukemia

Somedeb Ball, Akriti G Jain, Luis E. E. Aguirre, Najla Al Ali, Yumeng Zhang, Onyee Chan, Andrew T. Kuykendall, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David Swoboda, Rami S. Komrokji, David A. Sallman
Journal: Blood
Blood (2021) 138 (Supplement 1): 4138.
https://doi.org/10.1182/blood-2021-153681
Published: 2021
Journal Articles

Clinical Characteristics and Outcomes of Patients with Large Granular Lymphocytic Leukemia Treated with Methotrexate, Cyclophosphamide or Cyclosporine. a Large Single Institutional Retrospective Analysis

Ankita Tandon, DO, Ning Dong, MD, Yumeng Zhang, MD, Emilie Wang, MD, Todd C. Knepper, PharmD, Haipeng Shao, MD, Ling Zhang, MD, Leidy Isenalumhe, MD, Rami Komrokji, MD, Lubomir Sokol, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
https://doi.org/10.1182/blood-2020-141701
Published: 2020
Journal Articles

Large Granular Lymphocytic Leukemia with Coexisting Malignancies

Ning Dong, MD, Leidy Isenalumhe, MD, Yumeng Zhang, MD, Franco Castillo Tokumori, MD, Todd C. Knepper, PharmD, Rami Komrokji, MD, Ling Zhang, MD, Haipeng Shao, MD, Lubomir Sokol, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-136796
Published: 2020
Journal Articles

Hypomethylating Agent and Venetoclax Combination Therapy Yields Superior Outcomes When Compared to Hypomethylating Agent Monotherapy in Patients ≥70 Years with Acute Myeloid Leukemia

Yumeng Zhang, MD, Hannah H Asghari, MD, Onyee Chan, MD, Dasom Lee, MD, Martine Extermann, MD, Najla Al Ali, M.Sc, Yehuda E. Deutsch, MD, Eric Padron, MD, Andrew T Kuykendall, MD, Alan F. List, MD, Hugo F. Fernandez, MD, Jeffrey E. Lancet, MD, Rami S. Komrokji, MD, David A Sallman, MD, Chetasi Talati, MD, Kendra L. Sweet, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1368.
https://doi.org/10.1182/blood-2019-127772
Published: 2019